See All Slides - tctmd.com

Slides

Presentation ACC 2013

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

Presenter: David R. Holmes, Jr.

March 08, 2013

Presentation ACC 2013

The ULTIMA Trial

Presenter: Nils Kucher

March 08, 2013

Presentation PCI Outcomes 2013

Clinical Approach to Multi-Vessel CAD

Presenter: Allen Jeremias

March 07, 2013

Presentation PCI Outcomes 2013

Case Presentation: DES Restenosis in 2013

Presenter: Philippe Généreux

March 07, 2013

Presentation PCI Outcomes 2013

A Common Sense Case Not Meeting the AUC

Presenter: Sripal Bangalore

March 07, 2013

Presentation PCI Outcomes 2013

Left Main Percutaneous Revascularization: Perspective on Advances in Method, Outcome and Clinical Decision Making

Presenter: David E. Kandzari

March 07, 2013

Presentation PCI Outcomes 2013

Strengths, Limitations and Real-world Implications of Appropriateness Use Criteria

Presenter: Dennis T. Ko

March 07, 2013

Presentation PCI Outcomes 2013

Updates and Revascularization Decisions - Case 1: PCI vs Medical Therapy in Stable Coronary Artery Disease

Presenter: Manish A. Parikh

March 07, 2013

Presentation PCI Outcomes 2013

DAPT + Oral Anticoagulation: Indications and Risk Amelioration

Presenter: C. Michael Gibson

March 07, 2013

Presentation PCI Outcomes 2013

Perspectives on PCI vs. Medical Therapy in Stable Coronary Artery Disease

Presenter: Gregg W. Stone

March 07, 2013

Advertisement

Slides

Randomized Trial of LAA Closure vs Warfarin for Stroke/ Thromboembolic Prevention in Patients with Non-valvular Atrial Fibrillation (PREVAIL)

The ULTIMA Trial

Clinical Approach to Multi-Vessel CAD

Case Presentation: DES Restenosis in 2013

A Common Sense Case Not Meeting the AUC

Left Main Percutaneous Revascularization: Perspective on Advances in Method, Outcome and Clinical Decision Making

Strengths, Limitations and Real-world Implications of Appropriateness Use Criteria

Updates and Revascularization Decisions - Case 1: PCI vs Medical Therapy in Stable Coronary Artery Disease

DAPT + Oral Anticoagulation: Indications and Risk Amelioration

Perspectives on PCI vs. Medical Therapy in Stable Coronary Artery Disease

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content